How have FBT shares performed in 2024?

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's stock was trading at GBX 1,526.10 on January 1st, 2024. Since then, FBT shares have decreased by 6.3% and is now trading at GBX 1,430.60. View the best growth stocks for 2024 here .

What other stocks do shareholders of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation own?

Based on aggregate information from My MarketBeat watchlists, some companies that other First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation investors own include Taylor Wimpey (TW) , Johnson & Johnson (JNJ) , Weyerhaeuser (WY) , AbbVie (ABBV) , ARK Innovation ETF (ARKK) , Alibaba Group (BABA) , Bristol-Myers Squibb (BMY) , Global X Robotics & Artificial Intelligence Thematic ETF (BOTZ) and Caterpillar (CAT) .

LON:FBT

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (FBT) Share Price, News & Analysis

→ Can't believe it's happening again (From Manward Press) (Ad)

Free FBT Stock Alerts

GBX 1,430.60

-4.90 (-0.34%)

(As of 04/16/2024 ET)

Compare

Today's Range: 1,418.84
▼
1,430.60
50-Day Range: 1,417
▼
1,495.60
52-Week Range: 1,313.70
▼
1,580.60

Volume: 10,238 shs
Average Volume: 1,303 shs
Market Capitalization: £4.23 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors

Get First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation alerts:

Ad Manward Press

Can't believe it's happening again

One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.

We explain how this event works in full right here.

About First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Stock (LON:FBT)

Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content. The company operates under the brand name of Blackbird. The company was founded in 1998 and is based in London, the United Kingdom.

FBT Stock Price History

30 days | 90 days | 365 days | Advanced Chart

FBT Stock News Headlines

January 22, 2024 | finance.yahoo.com

Net Asset Value(s)

September 27, 2023 | benzinga.com

First Trust Energy Infr: Dividend Insights

April 16, 2024 | Manward Press (Ad)

Can't believe it's happening again

May 11, 2023 | uk.investing.com

Lyxor NYSE Arca Gold BUGS (DR) UCITS ETF (CD91)

February 21, 2023 | money.usnews.com

First Trust NYSE Arca Biotech ETF

February 24, 2022 | apnews.com

CORRECTING and REPLACING First Trust Advisors L.P. Announces Distribution for First Trust Enhanced Short Maturity ETF

See More Headlines

Receive FBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Computer and Technology
Industry: Software - Application
Sub-Industry: N/A
Current Symbol: LON:FBT
CUSIP: N/A
CIK: N/A
Web: www.forbidden.co.uk
Phone: +44-20-88797245
Fax: N/A
Employees: 20
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 0.04
Current Ratio: 9.42
Quick Ratio: 9.27

Sales & Book Value

Annual Sales: £870,310.00
Price / Sales: 4,857.15
Cash Flow: GBX 403.66 per share
Price / Cash Flow: 3.54
Book Value: GBX 1.90 per share
Price / Book: 752.95

Miscellaneous

Outstanding Shares: 295,486,016
Free Float: N/A
Market Cap: £4.23 billion
Optionable: Not Optionable
Beta: N/A

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Mr. Ian McDonough (Age 47)
CEO & Director
Mr. Stephen B. Streater
Founder, Director of R&D and Exec. Director
Mr. Stephen James White (Age 48)
Chief Operating & Financial Officer and Director
Adrian Lambert
Marketing Director
Rachel Darcy
Sales Director

Key Competitors

View All Competitors

FBT Stock Analysis - Frequently Asked Questions

How have FBT shares performed in 2024?: First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's stock was trading at GBX 1,526.10 on January 1st, 2024. Since then, FBT shares have decreased by 6.3% and is now trading at GBX 1,430.60.
View the best growth stocks for 2024 here.
What other stocks do shareholders of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation own?: Based on aggregate information from My MarketBeat watchlists, some companies that other First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation investors own include Taylor Wimpey (TW), Johnson & Johnson (JNJ), Weyerhaeuser (WY), AbbVie (ABBV), ARK Innovation ETF (ARKK), Alibaba Group (BABA), Bristol-Myers Squibb (BMY), Global X Robotics & Artificial Intelligence Thematic ETF (BOTZ) and Caterpillar (CAT).
How do I buy shares of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation?: Shares of FBT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:FBT) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial